NCT05941832Completed
ANNE Sensor Monitoring in Cystic Fibrosis
ASM in CF:ANNE Sensor Monitoring in Cystic Fibrosis
Source: ClinicalTrials.gov · Last updated 29 May 2025
Brief summary (registry, in English)
The ANNE sensor is a small, wire free device that is placed on the chest with a removable adhesive patch. It measures things like temperature, heart rate and breathing rate without the need for wires and large machines that are needed currently. The aim is to trial this sensor in a small group of participants to see how well it is tolerated and how well it measures. The aim is to see if the sensor could provide additional information to help the medical team detect when a participant is becoming unwell with less need for the participant to perform repeated tests. Participants will wear the sensor for 6 weeks continuously (apart from when it is charged for 4-6 hours each day). Participants can perform their usual activities whilst wearing the sensor but should not submerse the sensor in water for long periods of time.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 10 (actual)
- First submitted
- 4 Jul 2023
- Start date
- 3 Jul 2023
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Papworth Hospital NHS Foundation Trust
- Diseases
- Cystic fibrosis
- NCT number
- NCT05941832
What you commit to
- Study type: Observational
- Participants enrolled: 10
- From 3 Jul 2023 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Lung transplant recipients.
Other illness
- Severe skin conditions e.g. psoriasis, severe eczema
Other
- Patients unable to provide written informed consent
- Patients who are currently not undertaking home monitoring / virtual clinics as part of Project Breathe
- Patients with a pacemaker
Who the study is looking for
- Diagnosis of Cystic Fibrosis based on genetic testing and /or sweat chloride levels.
- At least \>/= 18 years of age at time of consent
- Able to provide written informed consent
- Patients who are currently undertaking home monitoring / virtual clinics as part of Project Breathe
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal Papworth Hospital Coordinator of this site? Confirm its status | Cambridge | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.